Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

165 results
Display

A study of ribavirin therapy for type C chronic liver diseases

Kim YS, Seo DJ

  • KMID: 1685629
  • Korean J Gastroenterol.
  • 1993 Oct;25(5):914-917.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High dose-short duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

Ahn YM, Englund JA, Predra PA, Gilbert BE, Hiatt P

  • KMID: 1690785
  • Pediatr Allergy Respir Dis.
  • 1993 Dec;3(2):103-118.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sarcoidal Reaction on Old Scars during Pegylated Interferon-α and Ribavirin Therapy in a Patient with Chronic Hepatitis C

Kim SH, Lee KS, Oh BH, Kim SA

  • KMID: 2371095
  • Korean J Dermatol.
  • 2017 Feb;55(2):149-151.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

Yeon JE

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Allergic Contact Dermatitis to Ribavirin

Oh CW, Park MY, Hahm JH

Allergic contact dermatitis to topical agents mostly results from vehicles and preservatives and rarely from the active ingredients. Ribavirin, an active ingredient of Viramid® cream, is a synthetic nucleoside derivative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ribavirin Does Not Impair the Suppressive Activity of Foxp3+CD4+CD25+ Regulatory T Cells

Lee J, Choi YS, Shin EC

Ribavirin is an antiviral drug used in combination with pegylated interferon-alpha (IFN-alpha) for the treatment of hepatitis C virus (HCV) infection. Recently, ribavirin was reported to inhibit the suppressive activity...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Kumar R, Hsiang JC, Tan J, Thurairajah PH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can Non-invasive Fibrosis Assessment Predict Sustained Virological Response to Telaprevir with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients?

Kim MN, Kim JH, Kim SU

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients

Chung WJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peginterferon-alpha and Ribavirin Combination Therapy in Chronic Hepatitis C

Han KH, Yoon YH

  • KMID: 760535
  • Korean J Hepatol.
  • 2004 Jun;10(2):81-87.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Vitiligo in a Hepatitis C Patient after Pegylated Interferon Treatment

In SI, Kang HY

  • KMID: 2248144
  • Korean J Dermatol.
  • 2008 Jun;46(6):809-811.
The use of pegylated interferon (PEG-IFN) and ribavirin is considered standard therapy for patients with chronic hepatitis C. The treatment has been linked with a number of dermatologic manifestations such...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?

Jung YK, Kim JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study of Ribavirin (Virazole) in Herpes Zoster

Sung KJ, Kim KJ, Cinn YW, Kim WS, Kim HS, Lee YS

  • KMID: 1678128
  • Korean J Dermatol.
  • 1980 Dec;18(6):573-577.
Ribavirin(l-b-D-ribofuranosyl-l, 2, 4-triazole-3-carboximide, Virazole) is a. synthetic nucleoside derivative with reported broad spectrum activity in vitro and in vivo against a wide variety of DNA and RNA viruses. This drug...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cutaneous Sarcoidosis Associated with Pegylated Interferon Alpha-2a and Ribavirin Therapy

Kwon KH, Ha DC, Lee JH, Heo TY, Ahn YY, Kim YS, Lee DS

  • KMID: 2258872
  • Korean J Med.
  • 2011 Jun;80(Suppl 2):S117-S120.
Pegylated interferon plus ribavirin is the standard treatment regimen in chronic hepatitis C. The main adverse events of pegylated interferon plus ribavirin combination therapy are bone marrow depression, alopecia, insomnia,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment

Baek YH, Lee SW, Yoo HS, Yoon HA, Kim JW, Kim YH, Kim HY, Han SY

  • KMID: 2284055
  • Gut Liver.
  • 2007 Jun;1(1):87-89.
Combination therapy with inteferon-alpha and ribavirin is an approved therapy for patients with chronic hepatitis C. However, even with the use of pegylated interferon, response rates are still poor in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Trial of Ribavirin on Chroic Hepatitis B in Children

Hah JO, Hwang HY, Ma IY

To study the therapeutic effect of ribavirin, a broad spectrum antiviral agent, for chronic hepatitis B in pediatric patients, 24 patients who were diagnosed as chronic hepatitis B (elevated SGOT...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Generalized Eczema-like Eruption in a Patient Treated with Interferon Alpha-2b and Ribavirin for Chronic Hepatitis C

Kwon YS, Kim DS, Ryu DJ, Oh SH, Lee KH

  • KMID: 2248104
  • Korean J Dermatol.
  • 2008 Jul;46(7):915-918.
The combination of interferon alpha with ribavirin is currently recommended in the treatment of hepatitis C virus (HCV) infection. Commonly reported cutaneous reactions include localized reactions such as injection site...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Efficacy of Peginterferon and Ribavirin Combination Therapy for Chronic Hepatitis C among Korean, Caucasian and Other Asians

Kim KA

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea

Cho HC, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW

  • KMID: 1806676
  • Gut Liver.
  • 2013 Sep;7(5):585-593.
BACKGROUND/AIMS: Pegylated interferon (peginterferon) and ribavirin is the current standard therapy for chronic hepatitis C. The aims of this study were to evaluate the efficacy of peginterferon and ribavirin and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection

Kim DY

  • KMID: 1792354
  • Gut Liver.
  • 2014 Jul;8(4):335-336.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr